Xiaoqing Zhang Selected Research

Opioid Receptors (Opioid Receptor)

2/2021	Fentanyl inhibits acute myeloid leukemia differentiated cells and committed progenitors via opioid receptor-independent suppression of Ras and STAT5 pathways.
10/2016	Functional modulation on macrophage by low dose naltrexone (LDN).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaoqing Zhang Research Topics

Disease

41	Neoplasms (Cancer) 02/2024 - 09/2004
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 01/2014
8	Neoplasm Metastasis (Metastasis) 12/2023 - 01/2020
8	Inflammation (Inflammations) 02/2023 - 10/2008
7	Breast Neoplasms (Breast Cancer) 11/2023 - 12/2010
6	Infections 12/2023 - 01/2012
5	Fibrosis (Cirrhosis) 02/2023 - 01/2021
5	Colitis 09/2022 - 01/2015
5	Melanoma (Melanoma, Malignant) 01/2022 - 01/2019
5	Cognitive Dysfunction 08/2020 - 01/2014
4	Myocardial Infarction 11/2023 - 11/2017
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023 - 01/2015
4	Cardiovascular Diseases (Cardiovascular Disease) 11/2022 - 11/2021
4	Carcinoma (Carcinomatosis) 01/2022 - 09/2008
4	Intrahepatic Cholestasis of Pregnancy 01/2022 - 08/2016
3	Pain (Aches) 04/2024 - 01/2014
3	Disease Progression 01/2024 - 12/2010
3	Hypoxia (Hypoxemia) 02/2023 - 10/2019
3	Paraganglioma (Paragangliomas) 05/2022 - 03/2018
3	Pheochromocytoma 05/2022 - 03/2018
3	Prostatic Neoplasms (Prostate Cancer) 11/2021 - 09/2013
3	Shock 01/2021 - 06/2014
3	Carcinogenesis 01/2019 - 09/2013
2	Glucose Intolerance 03/2024 - 10/2008
2	Stomach Neoplasms (Stomach Cancer) 01/2024 - 01/2019
2	Bacterial Infections (Bacterial Infection) 12/2023 - 08/2016
2	Triple Negative Breast Neoplasms 11/2023 - 01/2019
2	Ovarian Neoplasms (Ovarian Cancer) 11/2023 - 01/2021
2	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 10/2023 - 12/2019
2	Insulin Resistance 10/2023 - 03/2019
2	Hyperlipidemias (Hyperlipidemia) 08/2023 - 12/2018
2	Hypertrophy 11/2022 - 01/2021
2	Ventricular Remodeling 11/2022 - 01/2021
2	Critical Illness (Critically Ill) 02/2022 - 01/2022
2	Colorectal Neoplasms (Colorectal Cancer) 11/2021 - 01/2014
2	Wounds and Injuries (Trauma) 10/2021 - 01/2021
2	Bronchiolitis 01/2021 - 12/2019
2	Congenital Heart Defects (Congenital Heart Defect) 01/2021 - 05/2015

Drug/Important Bio-Agent (IBA)

9	Biomarkers (Surrogate Marker)IBA 10/2020 - 11/2013
8	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2014
7	Bile Acids and Salts (Bile Acids)IBA 01/2022 - 08/2016
6	ErbB Receptors (EGF Receptor)IBA 01/2024 - 06/2011
6	CytokinesIBA 11/2023 - 01/2019
4	NivolumabIBA 02/2024 - 01/2022
4	Pemetrexed (MTA)FDA Link 02/2024 - 01/2014
4	Tyrosine Kinase InhibitorsIBA 01/2024 - 01/2016
4	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2019
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2024 - 06/2019
4	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 08/2016
4	Therapeutic UsesIBA 09/2023 - 01/2019
4	LipidsIBA 08/2023 - 10/2016
4	Anesthetics (Anesthetic Agents)IBA 08/2020 - 01/2012
4	Sevoflurane (Ultane)FDA LinkGeneric 08/2020 - 01/2017
3	Insulin (Novolin)FDA Link 03/2024 - 10/2008
3	IpilimumabIBA 02/2024 - 01/2022
3	CarbonIBA 12/2023 - 12/2020
3	InterferonsIBA 11/2023 - 04/2016
3	NAD (NADH)IBA 11/2023 - 01/2014
3	Eosine Yellowish-(YS) (Eosin)IBA 02/2023 - 01/2021
3	Interleukin-6 (Interleukin 6)IBA 02/2023 - 04/2021
3	InflammasomesIBA 01/2022 - 01/2021
3	Interleukin-17 (Interleukin 17)IBA 01/2022 - 01/2021
3	Folic Acid (Vitamin M)FDA LinkGeneric 01/2022 - 10/2011
3	Lysine (L-Lysine)FDA Link 09/2021 - 01/2017
3	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 09/2014
3	Interleukin-33IBA 01/2021 - 01/2015
3	Paclitaxel (Taxol)FDA LinkGeneric 12/2020 - 12/2010
3	Antiviral Agents (Antivirals)IBA 12/2019 - 08/2014
3	MicroRNAs (MicroRNA)IBA 01/2019 - 05/2014
3	AntigensIBA 08/2016 - 09/2004
2	PlatinumIBA 01/2024 - 11/2023
2	IndolesIBA 10/2023 - 12/2019
2	oxidized low density lipoproteinIBA 08/2023 - 01/2021
2	Hematoxylin (Haematoxylon)IBA 02/2023 - 01/2022
2	Carcinoembryonic AntigenIBA 01/2023 - 09/2008
2	Caspase 1 (ICE Protease)IBA 11/2022 - 01/2021
2	SaltsIBA 09/2022 - 06/2014
2	LigandsIBA 09/2022 - 01/2019
2	3-methoxytyramine (methoxytyramine)IBA 05/2022 - 11/2020
2	Chimeric Antigen ReceptorsIBA 01/2022 - 01/2020
2	CateninsIBA 01/2022 - 01/2020
2	Interleukin-2 (IL2)IBA 01/2022 - 11/2021
2	InterleukinsIBA 04/2021 - 01/2015
2	Opioid Receptors (Opioid Receptor)IBA 02/2021 - 10/2016
2	Small Interfering RNA (siRNA)IBA 01/2021 - 01/2014
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2021 - 01/2019
2	Monoclonal AntibodiesIBA 01/2021 - 01/2015
2	Local AnestheticsIBA 01/2021 - 01/2015

Therapy/Procedure

26	Therapeutics 01/2024 - 09/2004
11	Drug Therapy (Chemotherapy) 02/2024 - 12/2010
6	Immunotherapy 01/2022 - 01/2019
4	Anesthesia 01/2021 - 09/2014
3	Cannula 10/2019 - 01/2012
2	Aftercare (After-Treatment) 01/2024 - 04/2012
2	General Anesthesia 02/2023 - 01/2021
2	Stents 01/2023 - 01/2022
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 11/2022 - 01/2022
2	Ligation 01/2022 - 05/2015
2	Castration 11/2021 - 12/2016
2	Orthopedic Procedures 01/2021 - 01/2021